Preliminary construction of value judgment framework of precision medicine technology_Chinese Journal of Evidence-Based Medicine

Authors：

ZHANG Jinsui ^1,2,3 , QIU Yingpeng ^2,3 , XIAO Yue ^2,3 , LIU Yuehua ^2,3 ,  ZHAO Kun ^2,3

1. School of Public Health, Fudan University, Shanghai 200032, P.R. China;
2. China National Health Development Research Center, Beijing 100191, P.R. China;
3. China National Center for Drug and Health Technology Assessment, Beijing 100191, P.R. China;

Corresponding?author：

ZHAO Kun, Email: zk317@yahoo.com

Keywords：

Precision medicine; Value framework; Expert consultation; Indicator system

DOI：

10.7507/1672-2531.202001061

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objectives To initially construct a scientific, reasonable and precision medicine technology value judgment framework suitable for China’s national conditions based on expert consultation method, so as to provide scientific value judgment system support for China's medical insurance decision-making.Methods The preliminary evaluation indicator system for precision medicine technology value was established by using literature analysis and expert consultation method, and the direct weighting method was used to determine the indicators weight.Results After two rounds of expert consultation, an indicator system suitable for the value judgment of precision medicine technology in China was constructed, including 5 primary indicators (health needs, health effects, economics, innovation and suitability) and 14 secondary indicators. Each indicator was weighted according to importance.Conclusions A set of precision medicine value judgment indicator system suitable for China has been initially established, which lays a certain foundation for further measurement research of the indicator system and provides a scientific basis for medical insurance decision-making.

Citation： ZHANG Jinsui, QIU Yingpeng, XIAO Yue, LIU Yuehua, ZHAO Kun. Preliminary construction of value judgment framework of precision medicine technology. Chinese Journal of Evidence-Based Medicine, 2020, 20(8): 918-922. doi: 10.7507/1672-2531.202001061 Copy

1.	National Library of Medicine. What is precision medicine? Available from: https://ghr.nlm.nih.gov/primer/precisionmedicine/definition.
2.	Mirnezami R, Nicholson J, Darzi A. Preparing for precision medicine. N Engl J Med, 2012, 366(6): 489-491.
3.	Jameson JL, Longo DL. Precision medicine--personalized, problematic, and promising. N Engl J Med, 2015, 372(23): 2229-2234.
4.	張華, 詹啟敏. 引領全球精準醫學發展推動健康中國 2030 建設. 中華骨與關節外科雜志, 2017, 10(6): 474-481.
5.	崔孟珣, 彭奕, 趙瑾, 等. 國內外新藥進醫保目錄的比較研究及對我國相關政策建議. 藥學實踐雜志, 2011, 29(3): 226-228.
6.	段曉托, 連桂玉, 賈耀珠. 我國創新藥進入醫保目錄的障礙與對策. 中國藥房, 2017, 28(4): 455-457.
7.	焦怡琳, 王吉春, 張群, 等. 中國在精準醫學領域面臨的機遇與挑戰. 中國公共衛生管理, 2015, 31(5): 601-603.
8.	Emery JCH, Zwicker JD. Innovation, productivity, and pricing: Capturing value from precision medicine technology in Canada. Healthc Manage Forum, 2017, 30(4): 197-199.
9.	葉瑤. 基于德爾菲法的困境兒童社會救助保護項目評估指標體系開發研究. 北京: 中國青年政治學院, 2016.
10.	王芳. 社區衛生服務績效評價指標體系研究. 武漢: 華中科技大學, 2006.
11.	呂亞蘭. 適宜衛生技術評估指標體系及評估方法研究. 重慶: 重慶醫科大學, 2013.
12.	張金穗, 邱英鵬, 肖月, 等. 精準醫學技術的國際價值判斷框架指標構建及歸納. 中國衛生經濟, 2020, 39(1): 26-29.
13.	曾光. 現代流行病學方法與應用. 北京: 北京醫科大學中國協和醫科大學聯合出版社, 1994.
14.	郭祖德, 周萍, 夏志遠, 等. 加拿大衛生技術評估機構研究:以加拿大藥物和衛生技術局為例. 中國衛生資源, 2016, 19(3): 187-190.
15.	陳曉煒, 陳錢, 耿勁松, 等. 多準則決策分析應用于醫療保險報銷的系統評價. 中國衛生資源, 2018, 21(3): 218-223.
16.	Hailey D. Toward transparency in health technology assessment: a checklist for HTA reports. Int J Technol Assess Health Care, 2003, 19(1): 1-7.
17.	嵇承棟, 朱琳懿, 萬悅竹, 等. 國際衛生技術評估機構協作網衛生技術評估報告清單解讀. 中國循證醫學雜志, 2016, 16(3): 369-372.

1. National Library of Medicine. What is precision medicine? Available from: https://ghr.nlm.nih.gov/primer/precisionmedicine/definition.
2. Mirnezami R, Nicholson J, Darzi A. Preparing for precision medicine. N Engl J Med, 2012, 366(6): 489-491.
3. Jameson JL, Longo DL. Precision medicine--personalized, problematic, and promising. N Engl J Med, 2015, 372(23): 2229-2234.
4. 張華, 詹啟敏. 引領全球精準醫學發展推動健康中國 2030 建設. 中華骨與關節外科雜志, 2017, 10(6): 474-481.
5. 崔孟珣, 彭奕, 趙瑾, 等. 國內外新藥進醫保目錄的比較研究及對我國相關政策建議. 藥學實踐雜志, 2011, 29(3): 226-228.
6. 段曉托, 連桂玉, 賈耀珠. 我國創新藥進入醫保目錄的障礙與對策. 中國藥房, 2017, 28(4): 455-457.
7. 焦怡琳, 王吉春, 張群, 等. 中國在精準醫學領域面臨的機遇與挑戰. 中國公共衛生管理, 2015, 31(5): 601-603.
8. Emery JCH, Zwicker JD. Innovation, productivity, and pricing: Capturing value from precision medicine technology in Canada. Healthc Manage Forum, 2017, 30(4): 197-199.
9. 葉瑤. 基于德爾菲法的困境兒童社會救助保護項目評估指標體系開發研究. 北京: 中國青年政治學院, 2016.
10. 王芳. 社區衛生服務績效評價指標體系研究. 武漢: 華中科技大學, 2006.
11. 呂亞蘭. 適宜衛生技術評估指標體系及評估方法研究. 重慶: 重慶醫科大學, 2013.
12. 張金穗, 邱英鵬, 肖月, 等. 精準醫學技術的國際價值判斷框架指標構建及歸納. 中國衛生經濟, 2020, 39(1): 26-29.
13. 曾光. 現代流行病學方法與應用. 北京: 北京醫科大學中國協和醫科大學聯合出版社, 1994.
14. 郭祖德, 周萍, 夏志遠, 等. 加拿大衛生技術評估機構研究:以加拿大藥物和衛生技術局為例. 中國衛生資源, 2016, 19(3): 187-190.
15. 陳曉煒, 陳錢, 耿勁松, 等. 多準則決策分析應用于醫療保險報銷的系統評價. 中國衛生資源, 2018, 21(3): 218-223.
16. Hailey D. Toward transparency in health technology assessment: a checklist for HTA reports. Int J Technol Assess Health Care, 2003, 19(1): 1-7.
17. 嵇承棟, 朱琳懿, 萬悅竹, 等. 國際衛生技術評估機構協作網衛生技術評估報告清單解讀. 中國循證醫學雜志, 2016, 16(3): 369-372.

Chinese Journal of Evidence-Based Medicine

Preliminary construction of value judgment framework of precision medicine technology

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content